NCI is the nation's leader in cancer research
Patients will receive drugs that target specific abnormalities in their tumors.
Analysis shows benefit from fewer than 3 doses of the HPV vaccine Cervarix.
NCI provides sustained support to scientists working to meet urgent, unmet needs in many areas of cancer research.
Discover more about what NCI does, what we fund, and some highlights from our long history in leading cancer research in this infographic.
Information about NCI Acting Director, Doug Lowy, M.D. and other senior NCI leaders.
Division of Cancer Biology
Visit DCB Site
Division of Cancer Control and Population Sciences
Visit DCCPS Site
Division of Cancer Epidemiology and Genetics
Visit DCEG Site
Division of Cancer Prevention
Visit DCP Site
Division of Cancer Treatment and Diagnosis
Visit DCTD Site
Division of Extramural Activities
Visit DEA Site
Center for Cancer Research
Visit CCR Site
Frederick National Laboratory for Cancer Research
Visit FNLCR Site
Center for Cancer Training
Visit CCT Site
Center for Cancer Genomics
Visit CCG Site
Center for Global Health
Visit CGH Site
Center to Reduce Cancer Health Disparities
Visit CRCHD Site
